Teratocarcinoma-Derived Growth Factor 1 (TDGF1) Peptide
-
- Target See all TDGF1 products
- TDGF1 (Teratocarcinoma-Derived Growth Factor 1 (TDGF1))
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunogen (Imm)
- Sequence
- YGRNCEHDVR KEN
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute pellet in distilled water where required. For Blocking studies, reconstitute pellet in 200µl distilled water to obtain a 0.5mg/ml peptide solution.
- Buffer
- 100µg of Lyophilised peptide, formulation De-ionized (DI) water.
- Storage
- -20 °C
- Storage Comment
- Shipped at ambient temperature, store at -20°C.
-
- Target
- TDGF1 (Teratocarcinoma-Derived Growth Factor 1 (TDGF1))
- Synonyms
- CR Peptide, CRGF Peptide, CRIPTO Peptide, CR1 Peptide, cripto Peptide, cb85 Peptide, tdgf1 Peptide, wu:fe01d04 Peptide, zgc:109829 Peptide, Cripto-1 Peptide, cr1 Peptide, cr1a Peptide, frl-1 Peptide, frl1 Peptide, xcr1 Peptide, TDGF1 Peptide, tdgf3 Peptide, cripto-3 Peptide, teratocarcinoma-derived growth factor 1 Peptide, teratocarcinoma-derived growth factor 1, member 3 L homeolog Peptide, teratocarcinoma-derived growth factor 1, member 1 Peptide, TDGF1 Peptide, Tdgf1 Peptide, tdgf1 Peptide, tdgf1.3.L Peptide, tdgf1.1 Peptide
-